secwatch.observer — SEC 8-K summary
======================================

Issuer:     GILEAD SCIENCES, INC. (GILD)
CIK:        0000882095
Form:       8-K
Filed at:   2026-05-20T20:15:36+00:00
Accession:  0001104659-26-064518
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Gilead Sciences issues $3.0B in senior notes across four tranches (4.250%-4.900%)
--------------------------------------------------------------------------------

- $500M 4.250% Senior Notes due 2028, $1B 4.400% due 2029, $1B 4.600% due 2031, $500M 4.900% due 2034.
- Notes sold in public offering under Form S-3 shelf; proceeds for general corporate purposes incl. M&A.
- Underwriting agreement dated May 14, 2026, with Barclays, BofA Securities, and Citigroup as reps.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882095/000110465926064518/0001104659-26-064518-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882095/000110465926064518/tm2615045d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-064518

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer